© Reuters.
(Reuters) – Thermo Fisher Scientific Inc (NYSE:) posted a 58.2% jump in quarterly profit on Wednesday, boosted by strength in its life sciences unit which makes raw materials for COVID-19 vaccines as well as robust sales of its analytical instruments.
The company’s net income rose to $1.83 billion, or $4.61 per share, for the second quarter ended July 3, from $1.16 billion, or $2.90 per share, a year earlier.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
Be the first to comment